APA (7th ed.) Citation

Scrivens, B., Daniele, P., Papazacharia, A., Donia, A., Bailey, C., Maghsoudlou, P., & Salvatore, S. (2026). Eighteen-month real-world outcomes of intravitreal aflibercept 8 mg in treatment-naïve neovascular age-related macular degeneration: A UK single-centre experience. Graefe's Archive for Clinical and Experimental Ophthalmology: Incorporating German Journal of Ophthalmology, 1. https://doi.org/10.1007/s00417-026-07513-9

Chicago Style (17th ed.) Citation

Scrivens, Benjamin, Pierluigi Daniele, Areti Papazacharia, Ahmed Donia, Clare Bailey, Panayiotis Maghsoudlou, and Serena Salvatore. "Eighteen-month Real-world Outcomes of Intravitreal Aflibercept 8 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A UK Single-centre Experience." Graefe's Archive for Clinical and Experimental Ophthalmology: Incorporating German Journal of Ophthalmology 2026: 1. https://doi.org/10.1007/s00417-026-07513-9.

MLA (9th ed.) Citation

Scrivens, Benjamin, et al. "Eighteen-month Real-world Outcomes of Intravitreal Aflibercept 8 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A UK Single-centre Experience." Graefe's Archive for Clinical and Experimental Ophthalmology: Incorporating German Journal of Ophthalmology, 2026, p. 1, https://doi.org/10.1007/s00417-026-07513-9.